Prostate cancer
Conditions
Interventions
After injecting ICG into the prostate gland, observe with a near infrared (NIR) camera and classify lymph flow. The ICG positive site within the template dissection area is dissected and additionally
Sponsors
National Cancer Center Hospital:Tsukiji Campus
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Diagnosed as prostate cancer pathologically by prostate biopsy 2) Diagnosed as localized prostate cancer (T1-2N0M0) or locally advanced cancer (T3aN0M0) by DRE, CT, MRI 3) 20 years old and over, under 75 4) ECOG performance status score: 0 and 1 5) With or without measurable lesions 6) Provision of pretreatment: No history of hormone therapy, no history of surgery in the pelvis, no history of operation of the prostate 7) No restrictions on concomitant medications and combination therapy 8) With regard to complications, there is no restriction as long as it is judged that robot-assisted prostatectomy and extended lymph node dissection is possible by the attending physician 9) About patient participation The patient got consent in writing from the patient himself
Exclusion criteria
Exclusion criteria: Exclude those with allergic history in ICG
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lymph flow evaluatable ratio, lymph flow pattern classifiable ratio, lymph flow pattern classifiable ratio by lesion site, classification lymph flow pattern intra-lymph node metastasis rate | — |
Countries
Japan
Contacts
Public ContactTomohiko Hara
National Cancer Center Hospital:Tsukiji Campus Urology division
Outcome results
None listed